Sperimentazioni terapeutiche

LEGATO-HD

what is legato-Hd

Legato-HD is a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of treatment with laquinimod in patients with Huntington's disease.